Source:http://linkedlifedata.com/resource/pubmed/id/15388992
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2004-9-24
|
pubmed:abstractText |
The AIDS epidemic in the developing world represents a major global crisis and an effective vaccine is imperative. However, many parasites are common in developing countries and can result in a state of chronic immune activation that is polarized towards a Th2 profile and which can potentially impair responses to vaccines or other infectious challenges. In this study we demonstrate that experimental Leishmania major infection of BALB/c mice inhibits responses to a DNA-based HIV-1 gag vaccine. L. major infection in BALB/c results in a polarized Th2 immune response. In this study naïve BALB/c mice immunized with the HIV-1 gag DNA vaccine mounted a cellular immune response against the vaccine antigen, HIV-1 gag. CD8+ T lymphocytes were able to respond in vitro to HIV-1 gag stimulation and secrete interferon (IFN)-gamma. However, L. major-infected, vaccinated BALB/c mice had a significantly reduced number of IFN-gamma-producing CD8+ T cells following in vitro stimulation with gag antigen. These data suggest that parasitic infection, which results in a Th2 profile, reduces the efficacy of DNA vaccines that are designed to induce antiviral CD8+ T cell responses.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1422-6405
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2004 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
177
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
185-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15388992-AIDS Vaccines,
pubmed-meshheading:15388992-Animals,
pubmed-meshheading:15388992-Antigens, Protozoan,
pubmed-meshheading:15388992-CD8-Positive T-Lymphocytes,
pubmed-meshheading:15388992-Genes, gag,
pubmed-meshheading:15388992-HIV-1,
pubmed-meshheading:15388992-Immune Tolerance,
pubmed-meshheading:15388992-Immunity, Cellular,
pubmed-meshheading:15388992-Leishmania major,
pubmed-meshheading:15388992-Leishmaniasis, Cutaneous,
pubmed-meshheading:15388992-Mice,
pubmed-meshheading:15388992-Mice, Inbred BALB C,
pubmed-meshheading:15388992-Vaccines, DNA
|
pubmed:year |
2004
|
pubmed:articleTitle |
Experimental Leishmania major infection suppresses HIV-1 DNA vaccine induced cellular immune response.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.
|